0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prenatal Cell-Free DNA Screening Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-37V15043
Home | Market Reports | Health| Reproductive Health
Global Prenatal Cell Free DNA Screening Market Research Report 2023
BUY CHAPTERS

Global Prenatal Cell-Free DNA Screening Market Research Report 2025

Code: QYRE-Auto-37V15043
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prenatal Cell-Free DNA Screening Market

The global market for Prenatal Cell-Free DNA Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Prenatal Cell-Free DNA Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prenatal Cell-Free DNA Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prenatal Cell-Free DNA Screening in Diagnostic Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prenatal Cell-Free DNA Screening include Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc, BGI, Natera Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal Cell-Free DNA Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal Cell-Free DNA Screening.
The Prenatal Cell-Free DNA Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prenatal Cell-Free DNA Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal Cell-Free DNA Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Prenatal Cell-Free DNA Screening Market Report

Report Metric Details
Report Name Prenatal Cell-Free DNA Screening Market
Segment by Type
  • Combined First Trimester Screening
  • Second Trimester Maternal Serum Screening
Segment by Application
  • Diagnostic Laboratories
  • Hospitals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc, BGI, Natera Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prenatal Cell-Free DNA Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prenatal Cell-Free DNA Screening Market report?

Ans: The main players in the Prenatal Cell-Free DNA Screening Market are Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc, BGI, Natera Inc

What are the Application segmentation covered in the Prenatal Cell-Free DNA Screening Market report?

Ans: The Applications covered in the Prenatal Cell-Free DNA Screening Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Prenatal Cell-Free DNA Screening Market report?

Ans: The Types covered in the Prenatal Cell-Free DNA Screening Market report are Combined First Trimester Screening, Second Trimester Maternal Serum Screening

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Combined First Trimester Screening
1.2.3 Second Trimester Maternal Serum Screening
1.3 Market by Application
1.3.1 Global Prenatal Cell-Free DNA Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal Cell-Free DNA Screening Market Perspective (2020-2031)
2.2 Global Prenatal Cell-Free DNA Screening Growth Trends by Region
2.2.1 Global Prenatal Cell-Free DNA Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prenatal Cell-Free DNA Screening Historic Market Size by Region (2020-2025)
2.2.3 Prenatal Cell-Free DNA Screening Forecasted Market Size by Region (2026-2031)
2.3 Prenatal Cell-Free DNA Screening Market Dynamics
2.3.1 Prenatal Cell-Free DNA Screening Industry Trends
2.3.2 Prenatal Cell-Free DNA Screening Market Drivers
2.3.3 Prenatal Cell-Free DNA Screening Market Challenges
2.3.4 Prenatal Cell-Free DNA Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal Cell-Free DNA Screening Players by Revenue
3.1.1 Global Top Prenatal Cell-Free DNA Screening Players by Revenue (2020-2025)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Players (2020-2025)
3.2 Global Prenatal Cell-Free DNA Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prenatal Cell-Free DNA Screening Revenue
3.4 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio
3.4.1 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal Cell-Free DNA Screening Revenue in 2024
3.5 Global Key Players of Prenatal Cell-Free DNA Screening Head office and Area Served
3.6 Global Key Players of Prenatal Cell-Free DNA Screening, Product and Application
3.7 Global Key Players of Prenatal Cell-Free DNA Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal Cell-Free DNA Screening Breakdown Data by Type
4.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Type (2020-2025)
4.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Type (2026-2031)
5 Prenatal Cell-Free DNA Screening Breakdown Data by Application
5.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Application (2020-2025)
5.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prenatal Cell-Free DNA Screening Market Size (2020-2031)
6.2 North America Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025)
6.4 North America Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal Cell-Free DNA Screening Market Size (2020-2031)
7.2 Europe Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025)
7.4 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size (2020-2031)
8.2 Asia-Pacific Prenatal Cell-Free DNA Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal Cell-Free DNA Screening Market Size (2020-2031)
9.2 Latin America Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025)
9.4 Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size (2020-2031)
10.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yourgene Health
11.1.1 Yourgene Health Company Details
11.1.2 Yourgene Health Business Overview
11.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Introduction
11.1.4 Yourgene Health Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.1.5 Yourgene Health Recent Development
11.2 Illumina Inc
11.2.1 Illumina Inc Company Details
11.2.2 Illumina Inc Business Overview
11.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Introduction
11.2.4 Illumina Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.2.5 Illumina Inc Recent Development
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Details
11.3.2 Agilent Technologies Inc Business Overview
11.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Introduction
11.3.4 Agilent Technologies Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.3.5 Agilent Technologies Inc Recent Development
11.4 Thermo Fisher Scientific Inc
11.4.1 Thermo Fisher Scientific Inc Company Details
11.4.2 Thermo Fisher Scientific Inc Business Overview
11.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Introduction
11.4.4 Thermo Fisher Scientific Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.4.5 Thermo Fisher Scientific Inc Recent Development
11.5 Hoffmann-La Roche Ltd
11.5.1 Hoffmann-La Roche Ltd Company Details
11.5.2 Hoffmann-La Roche Ltd Business Overview
11.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Introduction
11.5.4 Hoffmann-La Roche Ltd Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.5.5 Hoffmann-La Roche Ltd Recent Development
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Details
11.6.2 Laboratory Corporation of America Holdings Business Overview
11.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Introduction
11.6.4 Laboratory Corporation of America Holdings Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.6.5 Laboratory Corporation of America Holdings Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Introduction
11.7.4 GE Healthcare Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.7.5 GE Healthcare Recent Development
11.8 PerkinElmer Inc
11.8.1 PerkinElmer Inc Company Details
11.8.2 PerkinElmer Inc Business Overview
11.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Introduction
11.8.4 PerkinElmer Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.8.5 PerkinElmer Inc Recent Development
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Prenatal Cell-Free DNA Screening Introduction
11.9.4 BGI Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.9.5 BGI Recent Development
11.10 Natera Inc
11.10.1 Natera Inc Company Details
11.10.2 Natera Inc Business Overview
11.10.3 Natera Inc Prenatal Cell-Free DNA Screening Introduction
11.10.4 Natera Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025)
11.10.5 Natera Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Combined First Trimester Screening
 Table 3. Key Players of Second Trimester Maternal Serum Screening
 Table 4. Global Prenatal Cell-Free DNA Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Prenatal Cell-Free DNA Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Prenatal Cell-Free DNA Screening Market Share by Region (2020-2025)
 Table 8. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Prenatal Cell-Free DNA Screening Market Share by Region (2026-2031)
 Table 10. Prenatal Cell-Free DNA Screening Market Trends
 Table 11. Prenatal Cell-Free DNA Screening Market Drivers
 Table 12. Prenatal Cell-Free DNA Screening Market Challenges
 Table 13. Prenatal Cell-Free DNA Screening Market Restraints
 Table 14. Global Prenatal Cell-Free DNA Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Prenatal Cell-Free DNA Screening Market Share by Players (2020-2025)
 Table 16. Global Top Prenatal Cell-Free DNA Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Cell-Free DNA Screening as of 2024)
 Table 17. Ranking of Global Top Prenatal Cell-Free DNA Screening Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Prenatal Cell-Free DNA Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Prenatal Cell-Free DNA Screening, Headquarters and Area Served
 Table 20. Global Key Players of Prenatal Cell-Free DNA Screening, Product and Application
 Table 21. Global Key Players of Prenatal Cell-Free DNA Screening, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Prenatal Cell-Free DNA Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Type (2020-2025)
 Table 25. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Type (2026-2031)
 Table 27. Global Prenatal Cell-Free DNA Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Application (2020-2025)
 Table 29. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Application (2026-2031)
 Table 31. North America Prenatal Cell-Free DNA Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Prenatal Cell-Free DNA Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Prenatal Cell-Free DNA Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prenatal Cell-Free DNA Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Yourgene Health Company Details
 Table 47. Yourgene Health Business Overview
 Table 48. Yourgene Health Prenatal Cell-Free DNA Screening Product
 Table 49. Yourgene Health Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 50. Yourgene Health Recent Development
 Table 51. Illumina Inc Company Details
 Table 52. Illumina Inc Business Overview
 Table 53. Illumina Inc Prenatal Cell-Free DNA Screening Product
 Table 54. Illumina Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 55. Illumina Inc Recent Development
 Table 56. Agilent Technologies Inc Company Details
 Table 57. Agilent Technologies Inc Business Overview
 Table 58. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product
 Table 59. Agilent Technologies Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 60. Agilent Technologies Inc Recent Development
 Table 61. Thermo Fisher Scientific Inc Company Details
 Table 62. Thermo Fisher Scientific Inc Business Overview
 Table 63. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product
 Table 64. Thermo Fisher Scientific Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 65. Thermo Fisher Scientific Inc Recent Development
 Table 66. Hoffmann-La Roche Ltd Company Details
 Table 67. Hoffmann-La Roche Ltd Business Overview
 Table 68. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product
 Table 69. Hoffmann-La Roche Ltd Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 70. Hoffmann-La Roche Ltd Recent Development
 Table 71. Laboratory Corporation of America Holdings Company Details
 Table 72. Laboratory Corporation of America Holdings Business Overview
 Table 73. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product
 Table 74. Laboratory Corporation of America Holdings Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 75. Laboratory Corporation of America Holdings Recent Development
 Table 76. GE Healthcare Company Details
 Table 77. GE Healthcare Business Overview
 Table 78. GE Healthcare Prenatal Cell-Free DNA Screening Product
 Table 79. GE Healthcare Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 80. GE Healthcare Recent Development
 Table 81. PerkinElmer Inc Company Details
 Table 82. PerkinElmer Inc Business Overview
 Table 83. PerkinElmer Inc Prenatal Cell-Free DNA Screening Product
 Table 84. PerkinElmer Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 85. PerkinElmer Inc Recent Development
 Table 86. BGI Company Details
 Table 87. BGI Business Overview
 Table 88. BGI Prenatal Cell-Free DNA Screening Product
 Table 89. BGI Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 90. BGI Recent Development
 Table 91. Natera Inc Company Details
 Table 92. Natera Inc Business Overview
 Table 93. Natera Inc Prenatal Cell-Free DNA Screening Product
 Table 94. Natera Inc Revenue in Prenatal Cell-Free DNA Screening Business (2020-2025) & (US$ Million)
 Table 95. Natera Inc Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Prenatal Cell-Free DNA Screening Picture
 Figure 2. Global Prenatal Cell-Free DNA Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prenatal Cell-Free DNA Screening Market Share by Type: 2024 VS 2031
 Figure 4. Combined First Trimester Screening Features
 Figure 5. Second Trimester Maternal Serum Screening Features
 Figure 6. Global Prenatal Cell-Free DNA Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prenatal Cell-Free DNA Screening Market Share by Application: 2024 VS 2031
 Figure 8. Diagnostic Laboratories Case Studies
 Figure 9. Hospitals Case Studies
 Figure 10. Prenatal Cell-Free DNA Screening Report Years Considered
 Figure 11. Global Prenatal Cell-Free DNA Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Prenatal Cell-Free DNA Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Prenatal Cell-Free DNA Screening Market Share by Region: 2024 VS 2031
 Figure 14. Global Prenatal Cell-Free DNA Screening Market Share by Players in 2024
 Figure 15. Global Top Prenatal Cell-Free DNA Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Cell-Free DNA Screening as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Prenatal Cell-Free DNA Screening Revenue in 2024
 Figure 17. North America Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Prenatal Cell-Free DNA Screening Market Share by Country (2020-2031)
 Figure 19. United States Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Prenatal Cell-Free DNA Screening Market Share by Country (2020-2031)
 Figure 23. Germany Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Prenatal Cell-Free DNA Screening Market Share by Region (2020-2031)
 Figure 31. China Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Prenatal Cell-Free DNA Screening Market Share by Country (2020-2031)
 Figure 39. Mexico Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Prenatal Cell-Free DNA Screening Market Share by Country (2020-2031)
 Figure 43. Turkey Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Prenatal Cell-Free DNA Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Yourgene Health Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 47. Illumina Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 48. Agilent Technologies Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 50. Hoffmann-La Roche Ltd Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 51. Laboratory Corporation of America Holdings Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 52. GE Healthcare Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 53. PerkinElmer Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 54. BGI Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 55. Natera Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS